A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV

NCT06724640 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: VH4011499 low dose Injection
DRUG: VH4011499 high dose Injection
DRUG: Placebo

Sponsor

ViiV Healthcare